Close

Form EFFECT Theriva Biologics, Inc.

December 9, 2022 6:04 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 8, 2022
Accession Number: 0001104659-22-124554
Submission Type: POS AM
CIK: 0000894158
Company Name: Theriva Biologics, Inc.
File Number: 333-267294


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings